These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 932502)

  • 41. Rabbit macrophage interferons. II. Some physicochemical properties and estimations of molecular weights.
    Smith TJ; Wagner RR
    J Exp Med; 1967 Apr; 125(4):579-93. PubMed ID: 6066967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolism of interferon: hepatic clearance of native and desialylated interferon.
    Bocci V; Pacini A; Pessina GP; Bargigli V; Russi M
    J Gen Virol; 1977 Jun; 35(3):525-34. PubMed ID: 881617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radioimmunoassay of human beta interferon.
    Neurath AR; Strick N; Raj NB; Pitha PM
    J Interferon Res; 1982; 2(1):51-7. PubMed ID: 6180106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.
    Merigan TC; Sikora K; Breeden JH; Levy R; Rosenberg SA
    N Engl J Med; 1978 Dec; 299(26):1449-53. PubMed ID: 362211
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacokinetic comparison of leukocyte and Escherichia coli-derived human interferon type alpha.
    Sarkar FH
    Antiviral Res; 1982 May; 2(1-2):103-6. PubMed ID: 6179467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrofocusing of interferons induced by poly I:C in the serum and peritoneal exudate granulocytes of rabbits.
    Táborský I
    Arch Gesamte Virusforsch; 1974; 44(1):58-61. PubMed ID: 4823867
    [No Abstract]   [Full Text] [Related]  

  • 47. Circulating human interferon after intramuscular injection into animals and man.
    Cantell K; Pyhälä L; Strander H
    J Gen Virol; 1974 Dec; 25(3):453-5. PubMed ID: 4443796
    [No Abstract]   [Full Text] [Related]  

  • 48. Interferon therapy in multiple myeloma: failure of human fibroblast interferon administration to the course of light chain disease.
    Billiau A; Bloemmen J; Bogaerts M; Claeys H; Van Damme J; De Ley M; de Somer P; Drochmans A; Heremans H; Kriel A; Schetz J; Tricot G; Vermylen C; Verwilghen R; Waer M
    Eur J Cancer Clin Oncol; 1981 Aug; 17(8):875-82. PubMed ID: 6173221
    [No Abstract]   [Full Text] [Related]  

  • 49. Altered pharmacologic properties of liposome-associated human interferon-alpha. II.
    Eppstein DA
    J Interferon Res; 1982; 2(1):117-25. PubMed ID: 6180100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Interferons--its method of administration and adverse effect related to pharmacokinetics ].
    Furue H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):186-93. PubMed ID: 6582804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of the interferon-like activity in preparations of leukocyte pyrogen.
    Elfenbein DS; Murphy PA; Chesney PJ; Seto DS; Carver DH
    J Gen Virol; 1979 Jan; 42(1):185-7. PubMed ID: 569683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxicokinetics of Naja sputatrix (Javan spitting cobra) venom following intramuscular and intravenous administrations of the venom into rabbits.
    Yap MK; Tan NH; Sim SM; Fung SY
    Toxicon; 2013 Jun; 68():18-23. PubMed ID: 23537711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Interferon status and the activity of dsRNA-dependent enzymes in volunteers and influenza patients receiving human recombinant alpha 2-interferon (reaferon)].
    Lavrukhina LA; Sokolova TM; Suetina IA; Kniazeva LD; Mironova LL
    Vopr Virusol; 1988; 33(5):580-5. PubMed ID: 2464241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Interferon production in multiple sclerosis].
    Khaletskaia EV; Fadeeva LL; Selezneva AIu; Priĭmiagi LS; Luka VIa
    Vopr Virusol; 1981; (2):218-21. PubMed ID: 6168116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Interferon production in healthy children and in those ill with acute respiratory and enterovirus infections. 2. Interferon production in patients with acute respiratory infections and its correlation with leukocyte interferon production].
    Solov'ev VD; Vorotyntsefa NV; Bektemirov TA; Kleĭmenova ZN; Fedorova IuB
    Vopr Virusol; 1969; 14(3):267-70. PubMed ID: 5820948
    [No Abstract]   [Full Text] [Related]  

  • 56. Pleural effusion disease in rabbits. Interferon in body fluids and tissues after experimental infection.
    Fennestad KL; Haahr S; Bruun L
    Acta Pathol Microbiol Scand B; 1979 Oct; 87(5):311-5. PubMed ID: 525355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cellular origin or rabbit serum interferon induced by Newcastle disease virus].
    Hellmann W; Kohlhage H
    Arch Gesamte Virusforsch; 1973; 40(3):334-40. PubMed ID: 4349398
    [No Abstract]   [Full Text] [Related]  

  • 58. Interferon and 2',5'-oligo(A) synthetase activities in serum and blood mononuclear leukocytes of cattle after injection of bovine interferon-alpha 1.
    Perino LJ; Short EC; Burge LJ; Winter DA; Fulton RW
    Am J Vet Res; 1990 Jun; 51(6):886-92. PubMed ID: 1695068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The lymphatic route. VI. Distribution of recombinant interferon-alpha 2 in rabbit and pig plasma and lymph.
    Bocci V; Pessina GP; Paulesu L; Nicoletti C
    J Biol Response Mod; 1988 Aug; 7(4):390-400. PubMed ID: 3171601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human leukocyte interferon has no structural or biological relationship to corticotropin.
    Wetzel R; Levine HL; Hagman J; Ramachandran J
    Biochem Biophys Res Commun; 1982 Feb; 104(3):944-9. PubMed ID: 6176236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.